AI Research Analyst — Briefing Mode

Evidence-backed cohort discovery and validated evidence profiles

See the strongest population patterns Alethos has identified for 5-year mortality risk and resilience, expressed as clear, readable profiles. Use the AI Research Analyst to understand which biomarker combinations matter most, communicate findings confidently, and shape interventions, programs, or commercial decisions around validated evidence.

At a Glance

  • General: Explore biomarker patterns and individual characteristics Alethos uncovered that separate high-risk from resilient populations.
  • Health: Turn validated risk profiles into targeted outreach toward populations where interventions create measurable impact.
  • Insurance: Design tailored wellness incentives and prevention programs for specific member cohorts that reduce claims and improve overall health.

At-Risk Cohorts

Patterns identifying patients at elevated 5-year mortality risk

Critical
7.1x5-Year Mortality Risk
0%
100%

Elevated Creatinine to Albumin Ratio and Osmolality

Critical
8.9x5-Year Mortality Risk
0%
100%

Geriatric Congestive Heart Failure with Heavy Metal Exposure

Critical
9.8x5-Year Mortality Risk
0%
100%

Congestive Heart Failure with Equipment Dependency and Elevated Creatinine

Critical
5.9x5-Year Mortality Risk
0%
100%

Prior Cancer with Renal and Serum Albumin Markers

Critical
8.4x5-Year Mortality Risk
0%
100%

Physically Dependent Seniors with Low Albumin

Critical
7.8x5-Year Mortality Risk
0%
100%

Elderly with Reduced Arm Circumference and Toxic Exposure

Critical
7.0x5-Year Mortality Risk
0%
100%

Impaired Renal Function with Hypoalbuminemia and Substance Use

Critical
8.2x5-Year Mortality Risk
0%
100%

Hypoalbuminemia with Concurrent Elevated Creatinine

Critical
7.9x5-Year Mortality Risk
0%
100%

Congestive Heart Failure with Renal Dysfunction and BMI Extremes

Critical
8.7x5-Year Mortality Risk
0%
100%

Congestive Heart Failure with Co-occurring Malignancy and Albuminuria

Critical
6.8x5-Year Mortality Risk
0%
100%

Chronic Illness with Elevated Red Cell Distribution

Critical
7.6x5-Year Mortality Risk
0%
100%

Equipment-Dependent Seniors with Significant Pulse Pressure

Critical
6.3x5-Year Mortality Risk
0%
100%

Specialized Medical Equipment Requirement with Low Albumin

Critical
7.5x5-Year Mortality Risk
0%
100%

Geriatric Patients with Low Albumin Levels

Survival Archetypes

Patterns associated with favorable 5-year survival outcomes

Resilient
98%5-Year Survival Rate
0%
100%

Working-Age Adults with Low Metabolic and Environmental Stress

Resilient
99%5-Year Survival Rate
0%
100%

Vaccinated College Graduates under Sixty Years

Resilient
98%5-Year Survival Rate
0%
100%

Physically Capable Adults with Active Weight Management

Resilient
98%5-Year Survival Rate
0%
100%

Hepatitis B Vaccination with Low Environmental Exposure

Resilient
98%5-Year Survival Rate
0%
100%

Healthy Immune Markers with Active Weight Management

Resilient
98%5-Year Survival Rate
0%
100%

Healthy Medical History with Proactive Wellness Behaviors

Resilient
99%5-Year Survival Rate
0%
100%

Educated Mobile Adults with Active Weight Management

Resilient
98%5-Year Survival Rate
0%
100%

Younger Adults with Low Environmental Toxin Exposure

Resilient
98%5-Year Survival Rate
0%
100%

College Graduates with Healthy Blood and Low Toxicity

Resilient
98%5-Year Survival Rate
0%
100%

Full Hepatitis B Vaccination with Optimal Metabolic Markers

Resilient
98%5-Year Survival Rate
0%
100%

Normative Blood Pressure and Biomarkers in Younger Adults

Resilient
98%5-Year Survival Rate
0%
100%

Hepatitis B Vaccination Series with Metabolic Stability

Resilient
99%5-Year Survival Rate
0%
100%

Full HepB Vaccination Series with Optimal General Health

Resilient
98%5-Year Survival Rate
0%
100%

Metabolic and Platelet Stability with Youthful Age

Resilient
98%5-Year Survival Rate
0%
100%

Stable Glycemic Control with Low Heavy Metal Exposure

ALETHOS BRAIN

No Data

No hypothesis data available